Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation ...

Two popular medications used in the fight against obesity—semaglutide (Wegovy; Novo Nordisk) and tirzepatide (Zepbound; Eli Lilly)—are priced too high to be considered cost-effective by currently ...

Treating people in low-income countries for major depressive disorder can also help improve their physical health and household members' wellbeing, demonstrating that mental health treatments can be ...

In patients with muscle-invasive bladder cancer, trimodal therapy modestly improved quality of life compared with radical cystectomy but was not cost-effective at either 5 or 10 years. The high costs ...

Usual care provided 9.59 QALYs at a lifetime cost of $222,300, diet and exercise yielded 9.75 QALYs for $226,300, and semaglutide offered 10.48 QALYs at $273,500, with tirzepatide providing 10.68 ...

(Reuters) - An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become more cost-effective as their prices have fallen and studies have shown proof of their ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...

Durvalumab cost-effectiveness in limited-stage small cell lung cancer failed to meet US value thresholds despite longer ...

A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in ...